|New from NCI|
|Rectal Cancer Facebook Live Event|
|Tune into the NCI Facebook page on March 29 from 2:00 – 3:00 p.m. ET to learn about rectal cancer treatments and research, including an overview of clinical trials that are now open. This event features Dr. Carmen Allegra of NCI and the University of Florida and Dr. Debra Schrag of Harvard University.|
Eating Hints Updated
|Check out the recently updated Eating Hints: Before, During, and After Cancer Treatment. This publication explains why people undergoing treatment for cancer may have eating problems, identifies the types of eating problems they might have, and suggests ways to manage them.|
|Can the Number of Colorectal Polyps Be Reduced in Certain High-Risk People?|
Familial adenomatous polyposis (FAP) is a cancer syndrome that runs in certain families. People with FAP can develop hundreds to thousands of polyps in the colon and rectum. Learn about a drug combination that may reduce polyps in people with FAP.
|Many Men with Penile Cancer Do Not Get Recommended Treatment|
Many men with penile cancer that has spread to nearby lymph nodes do not receive recommended treatments that could help them live longer. Learn about the challenges in treating and making progress against this disease.
|New Approval of Targeted Therapy Expands Initial Treatment Options for Advanced Breast Cancer|
The Food and Drug Administration has expanded the approved uses for the targeted therapy drug abemaciclib (Verzenio). Learn about this drug and how it can be used in women with advanced breast cancer.
|Experimental Targeted Therapy Shows Promise, Regardless of Cancer Type|
Early results suggest that a targeted therapy called larotrectinib may be effective in adult and pediatric patients with a wide variety of cancer types.
|PDQ Summary Updates|
We’ve updated our PDQ summary on treatment for bladder cancer to include the latest tests used to stage the disease as well as updated descriptions and illustrations of the different stages.
No hay comentarios:
Publicar un comentario